Matches 1 - 50 out of 385 1 2 3 4 5 6 7 8 >

AcclaimIP-ad

Match Document Document Title
US20150147385 INTRAVENOUS SYNTHETIC CURCUMIN (S-CURCUMIN) FOR THE TREATMENT OF PROLIFERATIVE DISORDERS  
Compositions and methods for the treatment of proliferative disorders including proliferative such as breast, uterine cervical, ophthalmic, and pancreatic cancer by the administration of...
US20130190340 Small-Molecule-Targeted Protein Degradation  
Certain aspects of the invention relate to compounds, compositions and methods that are useful for treating or preventing a disease in a subject by enhancing the degradation of a protein. In other...
US20120108664 TRANSDERMAL DELIVERY OF BENEFICIAL SUBSTANCES EFFECTED BY A HOSTILE BIOPHYSICAL ENVIRONMENT  
The present invention generally relates to the transdermal delivery of substances In one aspect, various methods for the transdermal delivery of beneficial substances are disclosed. By creating a...
US20100317737 TOPICAL DELIVERY OF L-ARGININE TO CAUSE BENEFICIAL EFFECTS  
The application of L-arginine and its derivatives to the skin causes beneficial effects of wound healing, increasing erectile function and increased growth of hair when applied in sufficient...
US20100316749 TOPICAL DELIVERY OF L-ARGININE TO CAUSE BENEFICIAL EFFECTS  
The application of L-arginine and its derivatives to the skin causes beneficial effects of wound healing, increasing erectile function and increased growth of hair when applied in sufficient...
US20120276152 SYSTEMS AND METHODS OF USING ZINC-CHELATOR TO TREAT MYOCARDIAL INFARCTION  
Methods and systems for treating an infarct by delivery of zinc chelator to modulate tissue.
US20140378534 TREATMENT AND DIAGNOSIS OF COLON CANCER  
The present invention discloses novel agents and methods for diagnosis and treatment of colon cancer. Also disclosed are related arrays, kits, and screening methods.
US20130224289 GASTRIC RETAINED GABAPENTIN DOSAGE FORM  
A method of treatment for epilepsy and other disease states is described, which comprises the delivery of gabapentin in a gastric retained dosage form.
US20120282307 GASTRIC RETAINED GABAPENTIN DOSAGE FORM  
A method of treatment for epilepsy and other disease states is described, which comprises the delivery of gabapentin in a gastric retained dosage form.
US20130216634 Herbal Supplement Prepared From Pelargonium Citronellum  
An extraction method for extracts of Pelargonium citronellum with improved methylhexaneamine content is provided. The method involves separating the oil phase from the aqueous phase; concentrating...
US20120225144 Herbal Supplement Prepared From Geranium  
An extraction method for extracts of Geranium or Pelargonium with improved methylhexaneamine content is provided. The method involves separating the oil phase from the aqueous phase; concentrating...
US20140107207 Method for Inactivating Viruses With Slightly Acidic Arginine  
The present invention provides a method for conveniently producing a protein formulation in which viruses are inactivated, without impairing the quality of the obtained protein formulation,...
US20150025063 Antiparkinsonian Action of Phenylisopropylamines  
A method of treating a subject for Parkinson's disease comprises administering said subject a phenylisopropylamine in an amount effective to treat said Parkinson's disease. In some embodiments the...
US20110166232 ENHANCEMENT OF UROGENITAL FUNCTION  
A method of treating nocturia in a human individual includes administering dosages of creatine to the individual; and reducing the dosages of creatine to the individual responsive to an increase...
US20110059906 Energy status of an individual by enhanced production of an endogenous fuel source  
The present invention relates to a method of improving the energy status of an individual by enhancing the usage of lactate. Improved lactate usage is accomplished through a composition comprising...
US20110236508 L-ARGININE-BASED FORMULATION FOR ORAL ABSORPTION  
A formulation comprising large quantities of l-arginine and/or fat plaque dissolving agents which is palatable, stench free, and does not evoke nausea. The formulation is adapted to facilitate the...
US20130281410 METHODS FOR THE TREATMENT OF PSYCHIATRIC DISORDERS  
The invention provides methods for the treatment of major depressive disorder in male subjects and methods for the treatment of psychiatric disorders at high altitudes by administering one or more...
US20130131175 CREATINE ORAL SUPPLEMENTATION USING CREATINE HYDROCHLORIDE SALT  
The present invention is directed to a third generation form of creatine, specifically a creatine hydrochloride salt, that drives significant improvements in muscle development and recovery due to...
US20110034421 CREATINE ORAL SUPPLEMENTATION USING CREATINE HYDROCHLORIDE SALT  
The present invention is directed to a third generation form of creatine, specifically a creatine hydrochloride salt, that drives significant improvements in muscle development and recovery due to...
US20090060922 Acetamide Stereoisomer  
The compound of formula (I) is a water-stable, long acting β2-selective adrenoceptor agonist useful as a bronchodilator in the treatment of bronchoconstriction associated with reversible...
US20060228396 ARGININE-CONTAINING COMPOSITIONS AND METHODS FOR INCREASING BLOOD FLOW USING SAME  
A composition for increasing blood flow is provided, wherein side effects such as lowering of blood pressure are reduced and blood flow is effectively increased in the capillaries. A composition...
US20110077198 COMPOSITIONS AND METHODS FOR INHIBITING THE ACTIVATION OF DSRNA-DEPENDENT PROTEIN KINASE AND TUMOR GROWTH INHIBITION  
The present invention relates to compositions and methods for preventing and treating a condition in a mammalian subject that include at least one inhibitor of double stranded RNA dependent...
US20150157558 METHODS OF TREATMENT USING A GASTRIC RETAINED GABAPENTIN DOSAGE FORM  
A method of treatment for epilepsy and other disease states is described, which comprises delivery of gabapentin in a gastric retained dosage form.
US20070117867 Kit comprising three independent compositions and methods for building muscle, increasing strength, increasing muscle size, increasing muscle performance and reducing muscle fatigue  
A kit, and a method of using same, that comprises first, second and third components wherein the first, second and third components collectively comprise Glycine, Arginine, Leucine, Creatine,...
US20140302141 Triple Combination Release Multi-layered Tablet  
This invention pertains to a multi-layered tablet for a triple combination release of active agents to an environment of use. More particularly, the invention pertains to a multi-layered tablet...
US20120065261 Creatine compositions for skin treatment  
The present invention relates to the use of creatine compounds, such as, for example, creatine monohydrate, creatine pyruvate and creatine ascorbate, for the treatment of skin.
US20150197809 METHODS AND ASSAYS RELATING TO HUNTINGTONS DISEASE AND PARKINSON'S DISEASE  
Described herein are methods for the diagnosis, prognosis, and treatment of neurological conditions, e.g. Huntington's Disease and Parkinson's Disease, relating to the misregulation of miRNAs in...
US20110112188 Treatment of Inflammatory Conditions  
The invention relates to methods of inhibiting production and function of 3-deoxyglucosone and other alpha-dicarbonyl sugars in skin thereby treating or prevention various diseases, disorders or...
US20150030579 HYDROXYTYROSOL COMBINATIONS FOR ENHANCING MITOCHONDRIAL FUNCTION AND ENERGY PRODUCTION  
Hydroxytyrosol or olive juice containing hydroxytyrosol in combination with at least one of the compounds selected from the group consisting of: creatine, coenzyme Q10, resveratrol, caffeine,...
US20150072966 METHOD OF PROMOTING WOUND HEALING  
A method of establishing a therapeutic window of wound fluid nitric oxide (WFNO) in the wound of a mammal, the method including: obtaining a wound fluid sample from a mammal; analyzing the WFNO...
US20120003158 Biomarkers for Inflammatory Bowel Disease and Methods Using the Same  
The present invention provides various biomarkers of inflammatory bowel disease, including biomarkers for Crohn's disease and biomarkers for Ulcerative colitis. The present invention also provides...
US20080182903 Formulation of a composition for treating various conditions by using lotion/cream including L-Arginine  
Disclosed is a composition and method, for various conditions, including body weight control, sexual dysfunction, stomach blotting, heartburn, body pain, and controlling cholesterol, arginine is...
US20050256192 Nutritional composition for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging intense muscle pumps, supporting endurance, strength, performance, size and stamina, providing a transducer effect for nitric oxide, increasing nutrient delivery and/or promoting increased vascular response in an individual  
A nutritional composition, the consumption of which provides a method for enhancing lean muscle stimulus, growth, strength and recovery, creating and prolonging muscle pumps, supporting endurance,...
US20050186294 Method of using a compound of menthol and L-arginine as a preparation for the topical delivery of vardenafil for the treatment of female sexual dysfunction  
A manual application of a topical clitoral sensitizing compound combination in an applicator, consisting essentially of L-arginine and a cooling agent comprised of Menthol and vardenafil, wherein...
US20060229256 Enternal administration of arginine and glutamine for abnormal vascular proliferation  
The subject invention provides a method and compositions for preventing and/or treating abnormal vascular proliferation in a human infant where the method involves enterally administering arginine...
US20150223464 Compositions and Methods With Efficacy Against Spores And Other Organisms  
Compositions and methods for the disinfection of surfaces are provided. The compositions include at least about 40 weight percent of a C1-6 alcohol, and a primary enhancer selected from protein...
US20130289059 BENEFICIAL EFFECTS OF INCREASING LOCAL BLOOD FLOW  
The present invention generally relates to the improvement of tissue health by increasing local blood flow. In some aspects of the invention, increased local blood flow is effected by the...
US20110028548 BENEFICIAL EFFECTS OF INCREASING LOCAL BLOOD FLOW  
The present invention generally relates to the improvement of tissue health by increasing local blood flow. In some aspects of the invention, increased local blood flow is effected by the...
US20140288117 USE OF CYSTEAMINE IN TREATING PARKINSON'S DISEASE  
The subject invention provides materials and methods for treating neurodegenerative diseases. In one embodiment of the invention, a cysteamine compound is administered to a patient to treat...
US20050090545 Nitric oxide topical technology  
This invention with a new compound enables application of L-Arginine made with arginine alpha-ketoglutarate, arginine pyroglutamate, arginine ketoisocaproate and ornithine alpha-ketoglutarate to...
US20150053211 Cleaning and safe mouth guard solution  
An aqueous oral spray designed to treat mouth guards against bacterial infection comprising: 1. A naturally derived di-basic amino acid derivative,2. A natural sweetener which inhibits the...
US20060105064 Composition for treating skin ulcers  
An improved composition for treatment of ulcer-type skin conditions. The composition is primarily characterized by a combination of nitroglycerin and arginine. Other embodiments comprise emollient...
US20100056480 USE OF ARGINASE INHIBITORS IN THE TREATMENT OF ASTHMA AND ALLERGIC RHINITIS  
The present invention relates to the use of an arginase inhibitor for the preparation of a medicament for the prophylactic maintenance therapy of an asthmatic or allergic patient by preventing...
US20110300232 EFFECTS OF NITRIC OXIDE (NO) AND iNOS ON EXPRESSION AND SIGNAL TRANSDUCTION IN CANCER AND ITS USE IN DRUG DISCOVERY AND CANCER THERAPY DESIGN  
Nitric Oxide (NO) acts as double-edged sword, which induces and prevents cell death, depending on various factors. The mechanism for the NO regulation of cells is not fully understood. The present...
US20120237567 MODULATING LYMPHATIC FUNCTION  
Methods and compositions for modulating lymphatic function, e.g., by altering NO levels, are disclosed.
US20110196039 Controlled release arginine formulations  
A sustained release formulation of L-arginine alone or in combination with an agent which enhances the biotransformation of L-arginine into NO is described herein. FIG. 1A shows a schematic...
US20130273019 Compositions for Topical Treatment of Medical Conditions Including Wounds and Inflammation  
A method for treating a patient suffering from a wound, ulcer, or inflammation includes providing a topical formulation comprising a carrier and a combination of active ingredients that includes...
US20150190410 USE OF CREATINE AND PHOSPHOCREATINE IN THE TREATMENT OF EPILEPSY AND ALCOHOL ADDICTION  
The present invention relates to neurological disorders and treatment of epilepsy, seizures and alcoholism. In one embodiment, the present invention provides a method of treating the frequency of...
US20130217772 IBUPROFEN INTRAVENOUS INFUSION  
The present invention is a novel pharmaceutical formulation that compromises a four mg per ml (4 mg/mL) Ibuprofen in an aqueous solution of Arginine and Ibuprofen, wherein the molar ratio of...
US20130023581 ENVIRONMENTALLY ACTIVE CONCRETE  
In order to reduce the amount of an organism attractant substance remaining inside concrete that tends be used wastefully and also to allow the organism attractant substance to effectively flow...
Matches 1 - 50 out of 385 1 2 3 4 5 6 7 8 >